Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Winterlight Labs is a Canadian company revolutionizing the assessment and monitoring of cognitive health through advanced artificial intelligence. By analyzing subtle changes in speech and language patterns, their proprietary technology creates objective, data-driven digital biomarkers. These biomarkers help healthcare professionals detect, monitor, and assess the progression of various neurological and psychiatric conditions, including Alzheimer's disease, dementia, depression, and schizophrenia. Winterlight's platform aims to provide faster, more accessible, and less invasive tools for clinical trials, research, and patient care, ultimately improving outcomes for individuals affected by cognitive impairments.
Serves as the central hub for research and development, product innovation, strategic leadership, and corporate operations.
Located within the MaRS Discovery District, providing access to a vibrant ecosystem of researchers, startups, and healthcare institutions. Modern office facilities designed to foster collaboration and innovation.
Emphasizes innovation, scientific rigor, collaboration, and a patient-centric approach. Fosters a dynamic environment for researchers, engineers, and clinicians working on cutting-edge AI and healthcare solutions.
The MaRS Centre location is significant due to its concentration of talent, resources, and networking opportunities in the life sciences, AI, and technology sectors, facilitating partnerships and growth.
While headquartered in Toronto, Canada, Winterlight Labs's AI-powered cognitive assessment platform is designed for global application in clinical trials, research, and healthcare settings. The company collaborates with pharmaceutical companies, research institutions, and healthcare providers internationally to deploy its technology, supporting studies and patient monitoring across various regions.
MaRS Centre, West Tower, 661 University Ave, Suite 465
Toronto
Ontario
Canada
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Winterlight Labs' leadership includes:
Winterlight Labs has been backed by several prominent investors over the years, including:
No major C-suite executive hires or departures have been prominently announced for Winterlight Labs in the past 12 months. The current leadership team, including key VP roles, appears stable based on publicly available information.
Discover the tools Winterlight Labs uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Winterlight Labs commonly uses the [first].[last]@[companydomain.com] email format (e.g., jane.doe@winterlightlabs.com). This is a frequently observed pattern for companies in the technology and healthcare sectors.
[first].[last]@winterlightlabs.com
Format
jane.doe@winterlightlabs.com
Example
85%
Success rate
GlobeNewswire • July 17, 2023
Winterlight Labs and Eisai Inc. announced a collaboration to deploy Winterlight's speech-based digital biomarkers in Eisai's AHEAD 3-45 Phase III clinical study of lecanemab (brand name Leqembi®) in individuals with preclinical Alzheimer's disease who have intermediate or elevated levels of amyloid in their brains....more
Winterlight Labs Website (News) • October 18, 2023
Winterlight Labs announced its participation and presentation of new research findings at the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston, MA, from October 24-27, 2023. The presentations focused on advancements in speech-based digital biomarkers for early detection and monitoring of cognitive decline....more
Winterlight Labs Website (News) • May 10, 2023
Winterlight Labs' AI-powered speech analysis platform was selected to be part of the Innovative Medicines Initiative (IMI) project hypoSCRUb. This project aims to develop tools for better screening and understanding of hypoglycemia in diabetes patients, with Winterlight contributing its expertise in vocal biomarker technology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Winterlight Labs, are just a search away.